Hanger Announces Date of 2022 First Quarter Earnings Release and Conference Call

2022-04-21 11:47:20 By : Ms. Jasmine Fan

AUSTIN, Texas, April 13, 2022--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the first quarter and three months ended March 31, 2022 after the stock market closes on Wednesday, May 4, 2022.

Hanger’s management team will host a conference call to discuss the first quarter 2022 financial results the following morning on Thursday, May 5, 2022 at 8:30 a.m. Eastern time.

To participate in the Company’s live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 335781. A live webcast, replay of the call and earnings release, will be available on the Company’s Investor Relations website at investor.hanger.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About Hanger, Inc. – Headquartered in Austin, Texas, Hanger, Inc. (NYSE: HNGR) provides comprehensive, outcomes-based orthotic and prosthetic (O&P) services through its Patient Care segment, with approximately 875 Hanger Clinic locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. Recognized by Forbes as one of America’s Best Employers for 2022, and rooted in 160 years of clinical excellence and innovation, Hanger is a purpose-driven company with a vision to lead the O&P markets by providing superior patient care, outcomes, services and value, aimed at empowering human potential. For more information on Hanger, visit investor.hanger.com.

This earnings release contains statements that are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include information concerning our liquidity and our possible or assumed future results of operations, including descriptions of our business strategies. These statements often include words such as "believe," "expect," "project," "potential," "anticipate," "intend," "plan," "estimate," "seek," "will," "may," "would," "should," "could," "forecasts" or similar words. These statements are based on certain assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. We believe these assumptions are reasonable, but you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent releases or reports. These statements involve risks, estimates, assumptions, and uncertainties that could cause actual results to differ materially from those expressed in these statements and elsewhere in this release. These uncertainties include, but are not limited to, the financial and business impacts of COVID-19 on our operations and the operations of our customers, suppliers, governmental and private payers and others in the healthcare industry and beyond; federal laws governing the health care industry; governmental policies affecting O&P operations, including with respect to reimbursement; failure to successfully implement a new enterprise resource planning system or other disruptions to information technology systems; the inability to successfully execute our acquisition strategy, including integration of recently acquired O&P clinics into our existing business; changes in the demand for our O&P products and services, including additional competition in the O&P services market; disruptions to our supply chain; our ability to enter into and derive benefits from managed-care contracts; our ability to successfully attract and retain qualified O&P clinicians; labor shortages and increased turnover in our employee base; contractual, inflationary and other general cost increases, including with regard to costs of labor, raw materials and freight; and other risks and uncertainties generally affecting the health care industry. For additional information and risk factors that could affect the Company, see its Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission. The information contained in this press release is made only as of the date hereof, even if subsequently made available by the Company on its website or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220413005740/en/

Investor Relations Contact: Asher Dewhurst (443) 213-0503 HangerIR@westwicke.com

"I was surprised that people do not realize the magnitude of the Optimus robot program," the Tesla CEO said on the company's earnings call late Wednesday.

When it comes to building wealth, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett deserves to be in a class of his own. Although the Oracle of Omaha, as he's come to be known, isn't the wealthiest individual on the planet, he's delivered some of the most eye-popping investment returns over the past six decades. Since becoming CEO of Berkshire Hathaway in 1965, Buffett has overseen the creation of more than $760 billion in value for shareholders (himself included) and generated an average annual return of better than 20% on his company's stock.

The red-hot maker of graphics chips is facing headwinds that range from the aftereffects of pandemic-era spending to waning demand from gamers.

Nishit Madlani, S&P Global Ratings analyst and automotive sector lead, joins Yahoo Finance Live to discuss Tesla earnings, production issues due to COVID lockdowns in Shanghai, and the electric vehicle maker's plans to increase capacity at its gigafactories.

AT&T Inc. topped profit expectations for its latest quarter, the last full period to contain results from the WarnerMedia business that the telecommunications company has since spun off.

PayPal (NASDAQ: PYPL) investors have had a rough go of it lately, and Wednesday wasn't any better, with the stock down 6.7% as of 1:43 p.m. ET. The stock is now down nearly 70% from its 52-week highs. There wasn't much in the way of "new" news on Wednesday, but a financial analyst at SMBC Nikko Securities kept his "underweight" rating on the stock and lowered his price target.

Roblox (NYSE: RBLX) shareholders lost ground to the market on Wednesday as the stock fell 11% by 1:15 p.m. ET, compared to a slight increase in the S&P 500. The slump pushed shares of the video game and digital content specialist deeper into negative territory; they are down over 60% so far in 2022. It came as investors processed an unusually weak growth outlook from Netflix (NASDAQ: NFLX), another Wall Street favorite that has fallen out of favor recently.

The Dallas, Texas-based firm - whose WarnerMedia unit completed its merger with Discovery Inc earlier this month to form the new media firm Warner Bros. Discovery - added 691,000 monthly phone subscribers during the quarter. AT&T is refocusing on its original business of providing internet and phone services after unwinding a years-long effort to become a media and entertainment company. Shares of AT&T rose 1.5% to $19.73 in premarket trading.

Shares of the artificial intelligence lender Upstart (NASDAQ: UPST) fell roughly 9% today for no obvious reason. While I didn't see any formal news reports, multiple people on Twitter said that analysts at Jefferies had cut their price target for Upstart from $158 to $85. While other fintech stocks traded down today, Upstart trailed its peer group and most other financials as well.

The average holding in Ark Innovation (ARKK), Ark Investment Management’s namesake flagship exchange-traded fund, is currently down over 70% from its 5-year high.

A legendary investor has called a bottom for the Chinese stock market, but some investors still aren't sure.

Markets are well past the initial shock of Russia's invasion of Ukraine, but the conflict still needs to be resolved somehow. Here are the good, manageable and ugly scenarios.

Hedgeye's Keith McCullough adds gold, silver and utilities to survive the coming market downturn.

Yahoo Finance Live's Julie Hyman and Brian Sozzi discuss Piper Sandler reiterating its buy rating on chipmaker Nvidia.

Short-term stock market jitters are a great opportunity to pick up high-growth stocks like these at a discount.

Should you buy or sell Meta stock?

Yahoo Finance's Jared Blikre breaks down quarterly earnings results for United Airlines.

Shares of Walt Disney (NYSE: DIS) fell 5.6% on Wednesday after Netflix's (NASDAQ: NFLX) declining subscriber figures sparked concerns of intensifying competition in the streaming arena. Netflix lost 200,000 subscribers in the first quarter. The streaming pioneer said the launch of new streaming services from traditional entertainment companies was a key reason for its slowing growth.

In this article, we discuss 8 stocks to sell now according to Mitch Cantor’s Mountain Lake Investment Management. If you want to skip our detailed analysis of Cantor’s history, investment philosophy, and hedge fund performance, go directly to 4 Stocks to Sell Now According to Mitch Cantor’s Mountain Lake Investment Management. California-based hedge fund Mountain […]

A reasonably small amount of money can go a long way when it's invested in high-quality companies.